Especially, the expression of hsa-miR146b-5p in CD14+ monocytes of CH-C patients was remarkably lower than in the other groups (CH-B patients, NASH patients and healthy subjects)(Fig. 3B) (p < 0.01). Here, CD14 is linked to metabolic dysfunction-associated steatohepatitis.